These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38966681)

  • 61. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
    Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
    Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
    Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
    Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
    Tamura MK; Pajewski NM; Bryan RN; Weiner DE; Diamond M; Van Buren P; Taylor A; Beddhu S; Rosendorff C; Jahanian H; Zaharchuk G;
    Neurology; 2016 Mar; 86(13):1208-16. PubMed ID: 26920359
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials.
    Mann JFE; Hansen T; Idorn T; Leiter LA; Marso SP; Rossing P; Seufert J; Tadayon S; Vilsbøll T
    Lancet Diabetes Endocrinol; 2020 Nov; 8(11):880-893. PubMed ID: 32971040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
    Garimella PS; Lee AK; Ambrosius WT; Bhatt U; Cheung AK; Chonchol M; Craven T; Hawfield AT; Jotwani V; Killeen A; Punzi H; Sarnak MJ; Wall BM; Ix JH; Shlipak MG
    Eur Heart J; 2019 Nov; 40(42):3486-3493. PubMed ID: 31257404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.
    Heerspink HJL; Sattar N; Pavo I; Haupt A; Duffin KL; Yang Z; Wiese RJ; Tuttle KR; Cherney DZI
    Lancet Diabetes Endocrinol; 2022 Nov; 10(11):774-785. PubMed ID: 36152639
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial.
    Kim SH; Brodsky IG; Chatterjee R; Kashyap SR; Knowler WC; Liao E; Nelson J; Pratley R; Rasouli N; Vickery EM; Sarnak M; Pittas AG; ;
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1201-1209. PubMed ID: 34362787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
    Damman K; Gori M; Claggett B; Jhund PS; Senni M; Lefkowitz MP; Prescott MF; Shi VC; Rouleau JL; Swedberg K; Zile MR; Packer M; Desai AS; Solomon SD; McMurray JJV
    JACC Heart Fail; 2018 Jun; 6(6):489-498. PubMed ID: 29655829
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; Schueler E; Anker SD; Packer M
    JAMA Cardiol; 2022 Nov; 7(11):1148-1159. PubMed ID: 36129693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria : A Cohort Study.
    Verma A; Schmidt IM; Claudel S; Palsson R; Waikar SS; Srivastava A
    Ann Intern Med; 2024 Apr; 177(4):467-475. PubMed ID: 38560911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.
    Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):862-872. PubMed ID: 31160317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A population-based approach for the definition of chronic kidney disease: the CKD Prognosis Consortium.
    Cirillo M; Lombardi C; Mele AA; Marcarelli F; Bilancio G
    J Nephrol; 2012; 25(1):7-12. PubMed ID: 22038337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
    Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T
    Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.
    Stamellou E; Nadal J; Hendry B; Mercer A; Bechtel-Walz W; Schiffer M; Eckardt KU; Kramann R; Moeller MJ; Floege J;
    Clin Kidney J; 2024 Jul; 17(7):sfae131. PubMed ID: 38989280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of Albuminuria and Regression of Chronic Kidney Disease in Adults With Newly Diagnosed Moderate to Severe Chronic Kidney Disease.
    Pasternak M; Liu P; Quinn R; Elliott M; Harrison TG; Hemmelgarn B; Lam N; Ronksley P; Tonelli M; Ravani P
    JAMA Netw Open; 2022 Aug; 5(8):e2225821. PubMed ID: 35943741
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
    Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):691-704. PubMed ID: 29937267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD.
    Blum MF; Surapaneni A; Stewart JD; Liao D; Yanosky JD; Whitsel EA; Power MC; Grams ME
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):311-319. PubMed ID: 32108020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.
    Mosenzon O; Wiviott SD; Heerspink HJL; Dwyer JP; Cahn A; Goodrich EL; Rozenberg A; Schechter M; Yanuv I; Murphy SA; Zelniker TA; Gause-Nilsson IAM; Langkilde AM; Fredriksson M; Johansson PA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Sabatine MS; Raz I
    Diabetes Care; 2021 Aug; 44(8):1805-1815. PubMed ID: 34233928
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.